Switch theme
Sign up to access all valuation multiples
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
1874
316
Last FY Revenue $200M
Last FY EBITDA $37.3M
$282M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, IVF hartmann achieved revenue of $200M and an EBITDA of $37.3M.
IVF hartmann expects next 12-month revenue of XXX and NTM EBITDA of XXX
See IVF hartmann valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $200M | XXX | XXX | XXX |
| Gross Profit | XXX | $113M | XXX | XXX | XXX |
| Gross Margin | XXX | 57% | XXX | XXX | XXX |
| EBITDA | XXX | $37.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 19% | XXX | XXX | XXX |
| EBIT | XXX | $28.9M | XXX | XXX | XXX |
| EBIT Margin | XXX | 14% | XXX | XXX | XXX |
| Net Profit | XXX | $25.6M | XXX | XXX | XXX |
| Net Margin | XXX | 13% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, IVF hartmann's stock price is CHF 138 (or $174).
IVF hartmann has current market cap of CHF 331M (or $418M), and EV of CHF 224M (or $282M).
See IVF hartmann trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $282M | $418M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, IVF hartmann has market cap of $418M and EV of $282M.
IVF hartmann's trades at 1.4x EV/Revenue multiple, and 7.6x EV/EBITDA.
Equity research analysts estimate IVF hartmann's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
IVF hartmann's P/E ratio is not available.
See valuation multiples for IVF hartmann and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $418M | XXX | $418M | XXX | XXX | XXX |
| EV (current) | $282M | XXX | $282M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 7.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 9.7x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 16.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 12.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialIVF hartmann's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.
IVF hartmann's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IVF hartmann's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for IVF hartmann and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 42% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IVF hartmann acquired XXX companies to date.
Last acquisition by IVF hartmann was XXXXXXXX, XXXXX XXXXX XXXXXX . IVF hartmann acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was IVF hartmann founded? | IVF hartmann was founded in 1874. |
| Where is IVF hartmann headquartered? | IVF hartmann is headquartered in Switzerland. |
| How many employees does IVF hartmann have? | As of today, IVF hartmann has 316 employees. |
| Is IVF hartmann publicy listed? | Yes, IVF hartmann is a public company listed on SWX. |
| What is the stock symbol of IVF hartmann? | IVF hartmann trades under VBSN ticker. |
| When did IVF hartmann go public? | IVF hartmann went public in 2012. |
| Who are competitors of IVF hartmann? | Similar companies to IVF hartmann include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of IVF hartmann? | IVF hartmann's current market cap is $418M |
| Is IVF hartmann profitable? | Yes, IVF hartmann is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
